Short communication · 24 Sep 2022
Conference abstractPublished 4 Jul 2019
Biopharmaceutical formulation analysis
Protagen Protein Services GmbH, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Protagen Protein Services (PPS) is a world leading CRO and recognized expert for protein analytical services in the biopharmaceutical field. With two sites in Germany and since very recently a third site in Boston US we have more than 20 yearsâ?? experience in supporting customers in the biopharmaceutical, biotech and life science industry. We are partnering them throughout the entire process ranging from candidate selection to development and further to approval and GMP compliant release testing. The integrity of an API is essential for its required efficacy and safety. This integrity depends on the stability, secondary and tertiary structure, aggregation behavior and concentration of the developed molecule, factors which are highly influenced by the formulation of the API. We address such critical quality attributes by applying state of the art analysis techniques: During formulation studies orthogonal methods are used: To address aspects of higher order structure we apply orthogonal methods like FT-IR analysis in aqueous solution, CD analysis and fluorescence scan. Stability is elucidated by DSC equipped with autosampler, enabling high throughput screening. To assess aggregation behavior, we use highly sensitive DLS and AUC methods as well as SEC-methods equipped with MALLS detection and AF4-MALLS providing a broad range of orthogonal methods for detailed characterization. To precisely determine concentration, we offer AAA or HPLC and photometric techniques. As an expert in all these methods PPS is constantly extending its method portfolio and expertise to steadily improve our support in the formulation field for our sponsors. The poster presentation will illustrate the broad portfolio of methods available at PPS for formulation studies. If you are searching a partner in this field, please contact us. We are delighted to find the right answers to your questions in biopharmaceutical formulation analysis.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 28 Sep 2016
Use of Novel Flow Imaging Particle Analysis in Biopharmaceutical Formulation (FlowCam®)
Commentary · 29 Nov 2025
Oral Biopharmaceutical Delivery: Advanced Formulation Solutions
Article · 7 Jul 2025
Biopharmaceutical Characterization of Oral Insulin Formulations: Current Status and Future Prospects
Commentary · 30 Oct 2024
Formulation Development for Biopharmaceuticals: Overcoming Challenges in Delivery and Patient Compliance
More from this journal
The newest in Journal of Formulation Science & Bioavailability.
Opinion · 29 Nov 2025
AI Revolutionizing Pharmaceutical Formulation: Efficiency, Safety, Innovation
Opinion · 29 Nov 2025
Advanced Nanodrug Delivery for Poorly Soluble Drugs
Commentary · 29 Nov 2025
Oral Biopharmaceutical Delivery: Advanced Formulation Solutions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Formulation Science & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Natalie Perraudeau”
- BylineArticles whose byline prints “Burkhard Fleckenstein”

